18 F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis

Sho Furuya,Masanao Naya,Osamu Manabe,Kenji Hirata,Hiroshi Ohira,Tadao Aikawa,Kazuhiro Koyanagawa,Keiichi Magota,Ichizo Tsujino,Toshihisa Anzai,Yuji Kuge,Noriko Oyama-Manabe,Kohsuke Kudo,Tohru Shiga,Nagara Tamaki

18 F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis

2019

Sho Furuya
Masanao Naya
Osamu Manabe
Kenji Hirata
Hiroshi Ohira
Tadao Aikawa
Kazuhiro Koyanagawa
Keiichi Magota
Ichizo Tsujino
Toshihisa Anzai
Yuji Kuge
Noriko Oyama-Manabe
Kohsuke Kudo
Tohru Shiga
Nagara Tamaki

Background 18F-fluoromisonidazole (FMISO) is a hypoxia positron emission tomography (PET) tracer. Here, we evaluated cardiac and extra-cardiac sarcoidosis using both FMISO and 18F-fluorodeoxyglucose (FDG) PET/CT in a prospective cohort of patients with sarcoidosis.

Keywords:

Cardiac sarcoidosis
Sarcoidosis
18F-Fluoromisonidazole
Prospective cohort study
Radiology
FMISO
Medicine
Positron emission tomography
Hypoxia (medical)
PET-CT
Lung
Standardized uptake value

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations